UK markets close in 2 minutes
  • FTSE 100

    6,509.60
    -142.36 (-2.14%)
     
  • FTSE 250

    20,985.26
    -212.86 (-1.00%)
     
  • AIM

    1,181.84
    -10.02 (-0.84%)
     
  • GBP/EUR

    1.1510
    +0.0013 (+0.11%)
     
  • GBP/USD

    1.3923
    -0.0090 (-0.64%)
     
  • BTC-GBP

    34,448.34
    -2,530.66 (-6.84%)
     
  • CMC Crypto 200

    961.06
    +27.92 (+2.99%)
     
  • S&P 500

    3,823.65
    -5.69 (-0.15%)
     
  • DOW

    31,062.17
    -339.84 (-1.08%)
     
  • CRUDE OIL

    62.53
    -1.00 (-1.57%)
     
  • GOLD FUTURES

    1,724.10
    -51.30 (-2.89%)
     
  • NIKKEI 225

    28,966.01
    -1,202.26 (-3.99%)
     
  • HANG SENG

    28,980.21
    -1,093.96 (-3.64%)
     
  • DAX

    13,806.26
    -73.07 (-0.53%)
     
  • CAC 40

    5,711.15
    -72.74 (-1.26%)
     

Outlook on the Enteral Feeding Formulas Global Market to 2028 - by Product, Tube Type, Indication, End-use and Regions

Research and Markets
·9-min read

Dublin, Feb. 19, 2021 (GLOBE NEWSWIRE) -- The "Enteral Feeding Formulas Market Share, Size, Trends, Industry Analysis Report, By Product; By Tube Type, By Indication, By End Use, By Regions; Segment Forecast, 2021-2028" report has been added to ResearchAndMarkets.com's offering.

The global enteral feeding formulas market is expected to reach USD 9.37 billion by 2028. The report gives a detailed insight into current market dynamics and provides analysis on future market growth.

The global enteral feeding formulas industry is projected to grow, owing to rise in chronic disorders among old age population having low immunity, and the prevalent malnutrition in low-income countries, specifically poor nations with very low disposable income. Enteral feeding formulas industry players are focusing on customized feeding formulas to cater to particular indication.

The global enteral feeding formulas industry is fragmented based on the product, tube type, indication, end use, and region. In terms of product, the market is segmented into standard and disease specific formulas. The tube type market segment is further divided into nasogastric tube, naso-jejunal tube (NJT), Jejunostomy tubes, radiologically inserted gastronomy tubes (RIG), and percutaneous endoscopic gastronomy tubes (PEG).

The indication market segment is further divided into Alzheimer's, nutrition deficiency, cancer care, chronic kidney diseases, orphan diseases, dysphagia, pain management, malabsorption/GI disorder/Diarrhoea, and others. The end use market segment is further divided into hospitals, and long-term care facilities.

Segment Highlights

  • The standard enteral feeding formulas segment accounted for the largest revenue share in 2020 owing to easy availability at low cost. The market segment holds over 54% of the global share in 2020. Disease specific feeding formulas market is expected to expand at highest CAGR during the forecast period.

  • Based on indication, the nutritional deficiency segment is projected to constitute most of the market in 2028. The segment holds the major share due to the increasing occurrence of malnourishment among children across the world.

  • North America region is dominating the global enteral feeding formulas industry, holding almost one-third of the market share throughout forecast period. Due to change in the lifestyle and busy day to day activities there is a rise in chronic disorders and awareness of malnutrition in new-borns are the key factors responsible for growth in the region

  • Asia Pacific enteral feeding formulas industry comprises two most populous nations India and China, the region is expected to witness significant growth owing to the advancements in clinical research and high infant mortality rate due to malnutrition

Key Topics Covered:

1. Introduction

2. Executive Summary
2.1. Market Highlights

3. Research Methodology
3.1. Overview
3.1.1. Data Mining
3.2. Data Sources
3.2.1. Primary Sources
3.2.2. Secondary Sources

4. Enteral Feeding Formulas Market Insights
4.1. Enteral Feeding Formulas - Industry snapshot
4.2. Enteral Feeding Formulas Market Dynamics
4.2.1. Drivers and Opportunities
4.2.1.1. Malnutrition in newborns
4.2.1.2. Surge in chronic disorders
4.2.2. Restraints and Challenges
4.2.2.1. Infections and safety issues with feeding tubes
4.3. Porter's Five Forces Analysis
4.3.1. Bargaining Power of Suppliers (Moderate)
4.3.2. Threats of New Entrants: (Low)
4.3.3. Bargaining Power of Buyers (Moderate)
4.3.4. Threat of Substitute (Moderate)
4.3.5. Rivalry among existing firms (High)
4.4. PESTLE Analysis
4.5. Enteral Feeding Formulas Market Industry trends

5. Global Enteral Feeding Formulas Market Assessment by Product
5.1. Key Findings
5.2. Introduction
5.2.1. Global Enteral Feeding Formulas Market, By Product, 2016-2028 (USD Million)
5.3. Standard
5.3.1. Global Enteral Feeding Formulas Market, by Standard, by Region, 2016-2028 (USD Million)
5.3.2. Polymeric
5.3.2.1. Global Enteral Feeding Formulas Market, by Polymeric, by Region, 2016-2028 (USD Million)
5.3.3. Monomeric
5.3.3.1. Global Enteral Feeding Formulas Market, by Monomeric, by Region, 2016-2028 (USD Million)
5.4. Disease-Specific
5.4.1. Global Enteral Feeding Formulas Market, by Disease-Specific, by Region, 2016-2028 (USD Million)
5.4.2. Diabetic
5.4.2.1. Global Enteral Feeding Formulas Market, by Diabetic, by Region, 2016-2028 (USD Million)
5.4.3. Renal
5.4.3.1. Global Enteral Feeding Formulas Market, by Renal, by Region, 2016-2028 (USD Million)
5.4.4. Hepatic
5.4.4.1. Global Enteral Feeding Formulas Market, by Hepatic, by Region, 2016-2028 (USD Million)
5.4.5. Pulmonary
5.4.5.1. Global Enteral Feeding Formulas Market, by Pulmonary, by Region, 2016-2028 (USD Million)
5.4.6. Others
5.4.6.1. Global Enteral Feeding Formulas Market, by Other Disease-Specific Products, by Region, 2016-2028 (USD Million)

6. Global Enteral Feeding Formulas Market, by Tube Type
6.1. Key Findings
6.2. Introduction
6.2.1. Global Enteral Feeding Formulas Market, By Tube Type, 2016-2028 (USD Million)
6.3. Nasogastric Tube
6.3.1. Global Enteral Feeding Formulas Market, by Nasogastric Tube, By Region, 2016-2028 (USD Million)
6.4. Naso-jejunal tube (NJT)
6.4.1. Global Enteral Feeding Formulas Market, by Naso-jejunal tube (NJT), by Region, 2016-2028 (USD Million)
6.5. Jejunostomy Tubes
6.5.1. Global Enteral Feeding Formulas Market, by Jejunostomy Tubes, by Region, 2016-2028 (USD Million)
6.6. Radiologically inserted Gastronomy Tubes (RIG)
6.6.1. Global Enteral Feeding Formulas Market, by Radiologically inserted Gastronomy Tubes (RIG), by Region, 2016-2028 (USD Million)
6.7. Others
6.7.1. Global Enteral Feeding Formulas Market, by Other Tube Types, by Region, 2016-2028 (USD Million)

7. Global Enteral Feeding Formulas Market, by Indication
7.1. Key Findings
7.2. Introduction
7.2.1. Global Enteral Feeding Formulas Market, By Indication, 2016-2028 (USD Million)
7.3. Alzheimer's
7.3.1. Global Enteral Feeding Formulas Market, by Alzheimer's, By Region, 2016-2028 (USD Million)
7.4. Nutrition Deficiency
7.4.1. Global Enteral Feeding Formulas Market, by Nutrition Deficiency, by Region, 2016-2028 (USD Million)
7.5. Cancer Care
7.5.1. Global Enteral Feeding Formulas Market, by Cancer Care, by Region, 2016-2028 (USD Million)
7.6. Chronic Kidney Diseases
7.6.1. Global Enteral Feeding Formulas Market, by Chronic Kidney Diseases, by Region, 2016-2028 (USD Million)
7.7. Orphan Diseases
7.7.1. Global Enteral Feeding Formulas Market, by Orphan Diseases, by Region, 2016-2028 (USD Million)
7.8. Dysphagia
7.8.1. Global Enteral Feeding Formulas Market, by Dysphagia, by Region, 2016-2028 (USD Million)
7.9. Pain Management
7.9.1. Global Enteral Feeding Formulas Market, by Pain Management, by Region, 2016-2028 (USD Million)
7.10. Malabsorption/GI Disorder/Diarrhea
7.10.1. Global Enteral Feeding Formulas Market, by Malabsorption/GI Disorder/Diarrhea, by Region, 2016-2028 (USD Million)
7.11. Others
7.11.1. Global Enteral Feeding Formulas Market, by Other Indications, by Region, 2016-2028 (USD Million)

8. Global Enteral Feeding Formulas Market, by End-Use
8.1. Key Findings
8.2. Introduction
8.2.1. Global Enteral Feeding Formulas Market, By End-Use, 2016-2028 (USD Million)
8.3. Hospitals
8.3.1. Global Enteral Feeding Formulas Market, by Hospitals, By Region, 2016-2028 (USD Million)
8.3.2. Cardiology
8.3.2.1. Global Enteral Feeding Formulas Market, by Cardiology, By Region, 2016-2028 (USD Million)
8.3.3. Neurology
8.3.3.1. Global Enteral Feeding Formulas Market, by Neurology, By Region, 2016-2028 (USD Million)
8.3.4. Critical Care (ICU)
8.3.4.1. Global Enteral Feeding Formulas Market, by Critical Care (ICU), By Region, 2016-2028 (USD Million)
8.3.5. Oncology
8.3.5.1. Global Enteral Feeding Formulas Market, by Oncology, By Region, 2016-2028 (USD Million)
8.3.6. Others
8.3.6.1. Global Enteral Feeding Formulas Market, by Others, By Region, 2016-2028 (USD Million)
8.4. Long-term Care Facilities
8.4.1. Global Enteral Feeding Formulas Market, by Long-term Care Facilities, by Region, 2016-2028 (USD Million)
8.4.2. Homecare Agencies & Hospices
8.4.2.1. Global Enteral Feeding Formulas Market, by Homecare Agencies & Hospices, by Region, 2016-2028 (USD Million)
8.4.3. Nursing Homes
8.4.3.1. Global Enteral Feeding Formulas Market, by Nursing Homes, by Region, 2016-2028 (USD Million)
8.4.4. Assisted Living Facilities
8.4.4.1. Global Enteral Feeding Formulas Market, by Assisted Living Facilities, by Region, 2016-2028 (USD Million)

9. Global Enteral Feeding Formulas Market Assessment by Geography
9.1. Key findings
9.2. Introduction
9.3. Enteral Feeding Formulas Market - North America
9.4. Enteral Feeding Formulas Market - Europe
9.5. Enteral Feeding Formulas Market - Asia-Pacific
9.6. Enteral Feeding Formulas Market - Middle East & Africa
9.7. Enteral Feeding Formulas Market - Latin America

10. Competitive Landscape
10.1. Expansion and Acquisition Analysis
10.1.1. Expansion
10.1.2. Acquisition
10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles
11.1. Mead Johnson & Company, LLC
11.1.1. Company Overview
11.1.2. Financial Performance
11.1.3. Product Benchmarking
11.1.4. Recent Developments
11.2. Nestle Health Science
11.2.1. Company Overview
11.2.2. Financial Performance
11.2.3. Product Benchmarking
11.2.4. Recent Developments
11.3. Danone Nutricia
11.3.1. Company Overview
11.3.2. Financial Performance
11.3.3. Product Benchmarking
11.3.4. Recent Developments
11.4. Abbott Nutrition
11.4.1. Company Overview
11.4.2. Financial Performance
11.4.3. Product Benchmarking
11.4.4. Recent Developments
11.5. Kitchen Blends
11.5.1. Company Overview
11.5.2. Financial Performance
11.5.3. Product Benchmarking
11.5.4. Recent Developments
11.6. Meiji Holdings
11.6.1. Company Overview
11.6.2. Financial Performance
11.6.3. Product Benchmarking
11.6.4. Recent Developments
11.7. Otsuka Pharmaceutical Factory
11.7.1. Company Overview
11.7.2. Financial Performance
11.7.3. Product Benchmarking
11.7.4. Recent Developments
11.8. Diazyme Laboratories, Inc.
11.8.1. Company Overview
11.8.2. Financial Performance
11.8.3. Product Benchmarking
11.8.4. Recent Developments
11.9. Primus Pharmaceuticals, Inc.
11.9.1. Company Overview
11.9.2. Financial Performance
11.9.3. Product Benchmarking
11.9.4. Recent Developments
11.10. Fresenius Kabi AG
11.10.1. Company Overview
11.10.2. Financial Performance
11.10.3. Product Benchmarking
11.10.4. Recent Developments

For more information about this report visit https://www.researchandmarkets.com/r/tj973z

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900